Pharmacist Counseling on the Health-related Quality of Life of Patients With Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

February 1, 2018

Study Completion Date

August 31, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
BEHAVIORAL

Pharmacist Counseling Intervention

We used the counseling module (in the form of a guide book) for pharmacist-based counseling that had been validated regarding constructive content by an endocrinologist and a pharmacist expert in diabetes drug counseling. The module explained the T2DM causes and symptoms, the reasons for the importance of therapy, the non-pharmacological and pharmacological therapies available (drug names, strengths, indications, rules of use, side effects, interactions, and storage), the purpose of controlling blood sugar levels, medications that need to be avoided, and guidelines for missed doses. The pharmacists should explain all the content within the module in 15 minutes to each patient of the intervention group each month for 6 months. As an ethical consideration, the control group patients were given the same explanation module through pharmacist counseling after the study finished.

Trial Locations (4)

Unknown

Puskesmas Antang, Makassar

Puskesmas Batua, Makassar

Puskesmas Jongaya, Makassar

Puskesmas Tamalanrea, Makassar

All Listed Sponsors
collaborator

Ministry of Research, Technology and Higher Education of the Republic of Indonesia

UNKNOWN

lead

Universitas Padjadjaran

OTHER

NCT04313829 - Pharmacist Counseling on the Health-related Quality of Life of Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter